Literature DB >> 25274227

ALK inhibition for the treatment of refractory epithelioid inflammatory myofibroblastic sarcoma.

Mikihiro Fujiya1, Yutaka Kohgo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274227     DOI: 10.2169/internalmedicine.53.3038

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  6 in total

1.  Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Xuemei Du; Ying Gao; Hongyu Zhao; Bin Li; Weimin Xue; Daye Wang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

2.  Epithelioid inflammatory myofibroblastic sarcoma: a case report.

Authors:  Daniel E Sarmiento; Jessica A Clevenger; Gregory A Masters; Thomas L Bauer; Brian T Nam
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.

Authors:  Jun Zhou; Guozhong Jiang; Dandan Zhang; Lan Zhang; Jingjing Xu; Shenglei Li; Wencai Li; Yihui Ma; Ahong Zhao; Zhihua Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.

Authors:  Qiuyu Liu; Yunzhen Kan; Yuewu Zhao; Hui He; Lingfei Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 5.  Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.

Authors:  Xinge Fu; Juhong Jiang; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

6.  Epithelioid inflammatory myofibroblastic sarcoma: the youngest case reported.

Authors:  Sajida Batool; Arvind Ahuja; Devender Singh Chauhan; Minakshi Bhardwaj; Atul Kumar Meena
Journal:  Autops Case Rep       Date:  2021-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.